Main Determinants of Severe Neutropenia in Patients with Solid Tumors Receiving Adjuvant Chemotherapy

Journal Title: Iranian Journal of Blood and Cancer - Year 2012, Vol 5, Issue 1

Abstract

Background:Chemotherapy-induced neutropenia as a major toxicity of systemic chemotherapy is commonly associated with substantial mortality and morbidity, and thus identifying its determinants is necessary. This study was undertaken to identify main risk factors of severe neutropenia following adjuvant chemotherapy treatment in a community-based population of patients with cancer in Semnan, Iran. Materials and methods: This prospective study included 828 consecutive patients with histologically proven primary or metastatic solid tumors who received chemotherapy. Demographics data, disease characteristics, and co-morbidities (including current smoking and diabetes) were collected by face to face interviews with the patients and also by referring to their laboratory data and files. Patients underwent complete blood count a week after the first chemotherapy course. Results: Based on the nadir value of the absolute neutrophil count (ANC), 30 patients (3.6%) had severe neutropenia. Multivariable logistic regression analysis showed that advanced age (OR = 5.262, p = 0.012), and the presence of diabetes mellitus (OR = 8.126, p = 0.015) were the main determinants for the appearance of severe neutropenia with the presence of demographics and studied co-morbidities as confounders. Conclusion: We identified advanced age and the presence of diabetes as the main determinants of high-grade neutropenia in solid tumor patients receiving adjuvant chemotherapy in our study population. Keywords: Neutropenia, solid tumor, chemotherapy.

Authors and Affiliations

F. Ghahramanfard, Mohammad Faranoush, R Ghorbani, M. Rahbar

Keywords

Related Articles

Effect of Pamidronate on Osteoporosis in Patients with β-Thalassemia Major

Background: β-thalassemia major is a hereditary life threatening anemia which requires regular blood transfusion. Clinical symptoms of the disease are growth retardation, pallor, jaundice and skeletal alternations. The v...

In-Vitro Red Blood Cells Integrity and Morphology Changes after Passing Through Volumetric Peristaltic Infusion Pump

Background: It is not clear whether the use of volumetric peristaltic infusion pumps, affect the quality of the erythrocytes during packed cell transfusion or not. In the present study in vitro quality of red blood cells...

Antineoplastic Effect of Fenugreek (Trigonella Foenum Graecum) Seed Extract against Acute Myeloblastic Leukemia Cell Line (KG-1)

Background: Treatment of cancer patients using conventional chemotherapy causes serious side effects and, at best, merely extends the patient’s lifespan by a few years. The potential of alternative therapies may therefor...

Intravascular Hemolysis Due to Glucose‐6‐Phosphate Dehydrogenase Deficiency in a Patient with Aluminium Phosphide Poisoning

Aluminium Phosphide poisoning and glucose‐6‐phosphate dehydrogenase deficiency are two commonly seen clinical presentations in Iran. However, hemolysis associated with Aluminium Phosphide poisoning is very rare. We repor...

Download PDF file
  • EP ID EP366202
  • DOI -
  • Views 98
  • Downloads 0

How To Cite

F. Ghahramanfard, Mohammad Faranoush, R Ghorbani, M. Rahbar (2012). Main Determinants of Severe Neutropenia in Patients with Solid Tumors Receiving Adjuvant Chemotherapy. Iranian Journal of Blood and Cancer, 5(1), 3-7. https://europub.co.uk/articles/-A-366202